Baumer

Baumer Total Shareholder Payout

The Total Shareholder Payout of Baumer (BALM4.SA) as of Nov 9, 2026 is 7.48 M BRL. In the previous year, Total Shareholder Payout was 30,000.00 BRL — a change of 24,833.33% (higher).

Total Shareholder Payout

7.48 MBRL

YoY

24,833.33%

Last updated:

Total Shareholder Payout of Baumer is 2024 7.48 M BRL. Total Shareholder Payout of Baumer was 2023 30,000.00 BRL. It decreases by 24,833.33% higher compared to the previous year.

The Baumer Total Shareholder Payout history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Shareholder Payout
Date
Total Shareholder Payout
Jan 1, 2017
2.32 M BRL
Jan 1, 2018
4.11 M BRL
Jan 1, 2019
4.35 M BRL
Jan 1, 2020
2.88 M BRL
Jan 1, 2021
5.68 M BRL
Jan 1, 2022
5.05 M BRL
Jan 1, 2023
30,000.00 BRL
Jan 1, 2024
7.48 M BRL
The Baumer Total Shareholder Payout history
YEARTotal Shareholder PayoutYoY
7.48 MBRL+24,833.33%
30,000.00BRL-99.41%
5.05 MBRL-11.13%
5.68 MBRL+97.19%
2.88 MBRL-33.76%
4.35 MBRL+5.77%
4.11 MBRL+77.26%
2.32 MBRL-47.50%
4.42 MBRL+41.23%
3.13 MBRL-5.07%
3.29 MBRL—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Total Shareholder Payout of Baumer is 7.48 M BRL in 2024.

Total Shareholder Payout of Baumer changed from 30,000.00 BRL to 7.48 M BRL, representing a 24,833.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Shareholder Payout Baumer since 2006 – with annual values, charts, and detailed analysis.

Total shareholder payout combines dividends paid and share buybacks, representing the total cash returned to shareholders during the period.

Total Shareholder Payout's BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Shareholder Payout's Baumer historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Baumer

All Key Metrics — Baumer